South Australia researchers develop Parkinson's injection to replace pills

Researchers at the University of South Australia have developed an injectable medication for Parkinson's disease, potentially replacing the need for multiple daily pills. This could significantly improve patient convenience. The injection combines levodopa and carbidopa, two existing Parkinson's medications, into a single, biodegradable dose. It is designed to be injected weekly, releasing medication steadily over seven days. The research team has confirmed the formula's effectiveness in lab tests and plans to begin animal trials in six months. Parkinson's Australia has welcomed the development, noting the potential for improved patient quality of life.